Search

This issue includes items on antimicrobials, medication safety, diagnostics, COVID-19, and more. 

Also covered is the latest issue of Health Expectations along with early online papers from BMJ Quality & Safety and International Journal for Quality in Health Care and the latest from the USA’s AHRQ.

The Australian Group on Antimicrobial Resistance (AGAR) annually publishes data on antimicrobial resistance (AMR) and epidemiologic and genetic patterns in bloodstream infections in Australia, relating to three main organisms: enterococcal species, Staphylococcus aureus and gram-negative bacteria.

Released December 2023 

This issue includes items on antibiotic shortages, primary care, diagnosis, healthcare variation, leadership, endoscopy, COVID-19, medication safety and more.

Also covered are the latest issues of The Joint Commission Journal on Quality and Patient Safety, Healthcare Quarterly and health Affairs Scholar along with early online papers from BMJ Quality & Safety  and the International Journal for Quality in Health Care and the latest from the UK’s NICE and NIHR.

This resource provides information about antibiotic shortages for Aboriginal and Torres Strait Islander consumers.

This resource provides general information for health professionals working in Aboriginal Medical Services or Aboriginal Community Controlled Health Organisations. There is also a fact sheet for consumers.

This issue includes items on the AURA 2023 report on antimicrobial use and resistance, the OECD’s Health at Glance 2023, virtual wards, infusion pumps, alarms, quality and financial performance, COVID-19 and more.

Also covered are early online papers from International Journal for Quality in Health Care and the latest from the NSW Health’s ACI, the USA’s AHRQ and the UK’s NICE.

AURA 2023: Fifth Australian Report on Antimicrobial Use and Resistance in Human Health is being released on 16 November 2023, highlighting data trends and analyses across acute and community care settings. 

This Key Findings summary features the most compelling data findings from AURA 2023, with excerpts taken from the report for easy reference.

Australians are unwittingly being exposed to increased risk of harm from taking antibiotics, when often these medicines are used to treat common infections where they will have no or little benefit, according to the Australian Commission on Safety and Quality in Health Care.

Released 16 November 2023

This resource outlines what antimicrobial resistance (AMR) is, and how we need to limit our use of antimicrobials – such as antibiotics, antivirals, antifungals and antiparasitics – to reduce the risk of drug-resistant infections and impact of AMR.

AURA 2023: Fifth Australian Report on Antimicrobial Use and Resistance in Human Health was released on 16 November 2023, highlighting data trends and analyses across acute and community care settings. 

This A4 infographic showcases key data highlights from AURA 2023 on antimicrobial use in Australia.

This fact sheet provides information for consumers about antibiotic use and antibiotic resistance. It is designed to help clinicians and consumers answer the question, Do I really need antibiotics?

This fact sheet highlights key findings from AURA 2023 and priorities for action to support primary care services and clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.

This fact sheet highlights key findings from AURA 2023 and information about antimicrobial stewardship (AMS) and antimicrobial resistance (AMR), to support pharmacists working across primary and acute care settings.

This fact sheet highlights key findings from AURA 2023 and priorities for action to support infection prevention and control clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.

This fact sheet highlights key findings from AURA 2023 and priorities for action to support aged care services and clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.

This fact sheet highlights key conclusions and priorities for action identified in AURA 2023 to prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.